Treatment with Allopurinol is Associated with Lower Risk of Acute Kidney Injury in Patients with Gout: A Retrospective Analysis of a Nested Cohort

od Perez-Ruiz, Fernando
izdano v Rheumatol Ther (2017)

Improving adherence to gout therapy: an expert review

od Perez-Ruiz, Fernando, Desideri, Giovambattista
izdano v Ther Clin Risk Manag (2018)

A Review of Uric Acid, Crystal Deposition Disease, and Gout

od Perez-Ruiz, Fernando, Dalbeth, Nicola, Bardin, Tomas
izdano v Adv Ther (2014)

Hyperuricaemia with deposition: latest evidence and therapeutic approach

od Perez-Ruiz, Fernando, Marimon, Estibaliz, Chinchilla, Sandra P.
izdano v Ther Adv Musculoskelet Dis (2015)

Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout

od Khanna, Puja P., Perez-Ruiz, Fernando, Maranian, Paul, Khanna, Dinesh
Izdano 2011

High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?

od Perez-Ruiz, Fernando, Perez-Herrero, Nuria, Richette, Pascal, Stack, Austin G.
izdano v Rheumatol Ther (2020)

Gout. Imaging of gout: findings and utility

od Perez-Ruiz, Fernando, Dalbeth, Nicola, Urresola, Aranzazu, de Miguel, Eugenio, Schlesinger, Naomi
Izdano 2009

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol

od Perez-Ruiz, Fernando, Sundy, John S, Miner, Jeffrey N, Cravets, Matthew, Storgard, Chris
izdano v Ann Rheum Dis (2016)

Computational Lexical Analysis of the Language Commonly Used to Describe Gout

od Lawrence Edwards, N., Malouf, Robert, Perez‐Ruiz, Fernando, Richette, Pascal, Southam, Siobhan, DiChiara, Matthew
izdano v Arthritis Care Res (Hoboken) (2016)

Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study

od Dalbeth, Nicola, Jones, Graeme, Terkeltaub, Robert, Khanna, Dinesh, Fung, Maple, Baumgartner, Scott, Perez-Ruiz, Fernando
izdano v Arthritis Res Ther (2019)

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout

od Pérez-Ruiz, Fernando, Jansen, Tim, Tausche, Anne-Katrin, Juárez-Campo, Mónica, Gurunath, Ravichandra Karra, Richette, Pascal
izdano v Drugs Context (2019)

Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor Therapy

od Perez-Ruiz, Fernando, Jansen, Tim L., Tausche, Anne-Kathrin, Richette, Pascal, Lioté, Frédéric, So, Alexander K., Stack, Austin
izdano v Rheumatol Ther (2019)

Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality

od Pérez Ruiz, Fernando, Richette, Pascal, Stack, Austin G, Karra Gurunath, Ravichandra, García de Yébenes, Ma Jesus, Carmona, Loreto
izdano v RMD Open (2019)

Temporal trends in hyperuricaemia in the Irish health system from 2006-2014: A cohort study

od Kumar A. U., Arun, Browne, Leonard D., Li, Xia, Adeeb, Fahd, Perez-Ruiz, Fernando, Fraser, Alexander D., Stack, Austin G.
izdano v PLoS One (2018)

The burden of disease in Spain: results from the global burden of disease study 2010

od Haro, Josep Maria, Tyrovolas, Stefanos, Garin, Noe, Diaz-Torne, Cesar, Carmona, Loreto, Sanchez-Riera, Lidia, Perez-Ruiz, Fernando, Murray, Christopher JL
izdano v BMC Med (2014)

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

od Dalbeth, Nicola, Jones, Graeme, Terkeltaub, Robert, Khanna, Dinesh, Kopicko, Jeff, Bhakta, Nihar, Adler, Scott, Fung, Maple, Storgard, Chris, Baumgartner, Scott, Perez‐Ruiz, Fernando
izdano v Arthritis Rheumatol (2017)

Understanding the patient voice in gout: a quantitative study conducted in Europe

od De Meulemeester, Marc, Mateus, Elsa, Wieberneit-Tolman, Hilda, Betteridge, Neil, Ireland, Lucy, Petersen, Gudula, Maske, Nina Jeanette, Jansen, Tim L, Perez-Ruiz, Fernando
izdano v BJGP Open (2020)

Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice

od Perez Ruiz, Fernando, Sanchez-Piedra, Carlos A., Sanchez-Costa, Jesus T., Andrés, Mariano, Diaz-Torne, Cesar, Jimenez-Palop, Mercedes, De Miguel, Eugenio, Moragues, Carmen, Sivera, Francisca
izdano v Rheumatol Ther (2017)

Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group

od Grainger, Rebecca, Dalbeth, Nicola, Keen, Helen, Durcan, Laura, Edwards, N. Lawrence, Perez-Ruiz, Fernando, Diaz-Torne, Cesar, Singh, Jasvinder A., Khanna, Dinesh, Simon, Lee S., Taylor, William J.
izdano v J Rheumatol (2015)

Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence s...

od Cohen, Stanley, Genovese, Mark C, Choy, Ernest, Perez-Ruiz, Fernando, Matsumoto, Alan, Pavelka, Karel, Pablos, Jose L, Rizzo, Warren, Hrycaj, Pawel, Zhang, Nan, Shergy, William, Kaur, Primal
izdano v Ann Rheum Dis (2017)